Title:
経鼻投与用ワクチンを用いるインフルエンザの予防方法
Document Type and Number:
Japanese Patent JP5762307
Kind Code:
B2
Abstract:
The present invention provides a vaccine composition for transnasal mucous membrane administration, which contains an influenza virus antigen, polyriboinosinic polyribocytidylic acid (poly (I:C)) or a derivative thereof and a carboxyvinyl polymer. The present invention also provides a prophylactic method of influenza, including a step of administering the vaccine composition at least once to the nasal mucosa of a subject in need thereof.
Inventors:
Hideki Hasegawa
Sadao Manabe
Takeshi Tanimoto
Miya Saki Takashi
Top and bottom Taizo
Sadao Manabe
Takeshi Tanimoto
Miya Saki Takashi
Top and bottom Taizo
Application Number:
JP2011541970A
Publication Date:
August 12, 2015
Filing Date:
March 31, 2010
Export Citation:
Assignee:
Director, National Institute of Infectious Diseases
Research Foundation for Microbial Diseases, Osaka University
Toko Pharmaceutical Co., Ltd.
Research Foundation for Microbial Diseases, Osaka University
Toko Pharmaceutical Co., Ltd.
International Classes:
A61K39/145; A61K39/39; A61K47/32; A61P31/16
Domestic Patent References:
| JP3038529A |
Foreign References:
| WO2005014038A1 |
Other References:
VACCINE,1990,Vol.8,No.6,p.573-576
Journal of Virology,2005,Vol.9,No.5,p.2910-2919
JOURNAL OF INFECTIOUS DISEASES,2007,Vol.196,No.9,p.1313-1320
MICROBES AND INFECTION,2006,Vol.8,No.12-13,p.2706-2714
Journal of Virology,2005,Vol.9,No.5,p.2910-2919
JOURNAL OF INFECTIOUS DISEASES,2007,Vol.196,No.9,p.1313-1320
MICROBES AND INFECTION,2006,Vol.8,No.12-13,p.2706-2714
Attorney, Agent or Firm:
Junzo Watanabe